Literature DB >> 9373287

VATS-guided epicardial pacemaker implantation. Hand-sutured fixation of atrioventricular leads in an experimental setting.

M Furrer1, J Fuhrer, H J Altermatt, H Ris, D Mettler, U Althaus, T Carrel.   

Abstract

BACKGROUND: In neonates and infants epicardial stimulation may be preferred to endocardial stimulation because of growth-associated lead problems and the risk of vascular complications associated with transvenous electrodes. This study analyzes the feasibility of atrioventricular implantation of a new epicardial lead using the video-assisted thoracic surgical (VATS) technique in an animal model.
METHODS: Bipolar steroid-eluting epicardial leads were implanted in seven young white pigs. In five animals bipolar atrial and ventricular pacing leads (n = 10) were inserted and fixed by the VATS technique, while two animals served as controls and underwent implantation through anterolateral thoracotomy. Surgical feasibility, pacing, and sensing thresholds of the leads as well as hemodynamic parameters during pacing were studied. Histological changes beneath the electrodes were evaluated 1 week after the implantation.
RESULTS: All animals survived the pacemaker lead implantation. One animal which underwent thoracotomy died because of irreversible ventricular fibrillation induced by rapid ventricular pacing. One animal in the VATS group exhibited intraoperative herniation of the heart through the pericardial window. All animals with left-sided VATS implantations demonstrated good individual pacing and sensing threshold values. The mean cardiac output was 1.6 times higher during AAI-mode pacing as compared to VVI-mode pacing at a heart rate of 140/min. One animal died postoperatively due to respiratory failure. No displacements of the pacemaker leads were observed in the survivors.
CONCLUSION: While VATS-guided implantation of epicardial, atrial, and ventricular leads is feasible, technical improvements of the system are mandatory for safe clinical application.

Entities:  

Mesh:

Year:  1997        PMID: 9373287     DOI: 10.1007/s004649900562

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  5 in total

1.  [Left ventricular pacing and CRT. What CV lead fits into which vein?].

Authors:  B Hansky; J Vogt; H Gueldner; J Heintze; B Lamp; D Horstkotte; R Koerfer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006

2.  A hybrid form of cardiac resynchronisation therapy in patients with failing systemic right ventricles.

Authors:  Kevin A Michael; John R Paisey; Bongani M Mayosi; Stephen Robinson; Stuart Allen; Nadia S Sunni; Paul R Roberts; John M Morgan; Gruschen R Veldtman
Journal:  J Interv Card Electrophysiol       Date:  2008-10-04       Impact factor: 1.900

3.  Symbiotic cardiac pacemaker.

Authors:  Han Ouyang; Zhuo Liu; Ning Li; Bojing Shi; Yang Zou; Feng Xie; Ye Ma; Zhe Li; Hu Li; Qiang Zheng; Xuecheng Qu; Yubo Fan; Zhong Lin Wang; Hao Zhang; Zhou Li
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

4.  Wireless, battery-free, fully implantable multimodal and multisite pacemakers for applications in small animal models.

Authors:  Philipp Gutruf; Rose T Yin; K Benjamin Lee; Jokubas Ausra; Jaclyn A Brennan; Yun Qiao; Zhaoqian Xie; Roberto Peralta; Olivia Talarico; Alejandro Murillo; Sheena W Chen; John P Leshock; Chad R Haney; Emily A Waters; Changxing Zhang; Haiwen Luan; Yonggang Huang; Gregory Trachiotis; Igor R Efimov; John A Rogers
Journal:  Nat Commun       Date:  2019-12-17       Impact factor: 17.694

5.  Surgical implantation of a biventricular pacing system via lower half mini sternotomy.

Authors:  Morteza Tavakkoli Hosseini; Aron Frederik Popov; Antonios Kourliouros; Mazin Sarsam
Journal:  J Cardiothorac Surg       Date:  2013-01-12       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.